Detalhe da pesquisa
1.
Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications.
BMC Med
; 12: 98, 2014 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24927744
2.
Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future.
Front Pharmacol
; 7: 197, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27516740
3.
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications.
Front Pharmacol
; 5: 106, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24987370
4.
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.
Front Pharmacol
; 5: 109, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24959145
5.
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.
Front Pharmacol
; 4: 39, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23717279
6.
Discounts and rebates granted to public payers for medicines in European countries.
South Med Rev
; 5(1): 38-46, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23093898
7.
Potential to enhance the prescribing of generic drugs in patients with mental health problems in austria; implications for the future.
Front Pharmacol
; 3: 198, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23308071